logo

This website uses cookies to ensure you get the best experience on our website.

Read through the Privacy Policy to understand better

 Go Back

Concert: Q3 Earnings Snapshot

By AP News - Nov 07, 2022, 07:10 AM ET
Last Updated - Jun 23, 2023, 07:08 PM EDT
Concert: Q3 Earnings Snapshot

Concert: Q3 Earnings Snapshot

LEXINGTON, Mass. (AP) _ Concert Pharmaceuticals Inc. (CNCE) on Monday reported a loss of $28.9 million in its third quarter.

The Lexington, Massachusetts-based company said it had a loss of 58 cents per share.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 59 cents per share.

The biopharmaceutical company posted revenue of $8,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a CNCE">Zacks stock report on CNCE at https://www.zacks.com/ap/CNCE

Sponsored
Sponsored
Sponsored
Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
    Phone: +1 (425) 414-0184
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
    Phone: +91 80 4902 2100
4.2 20250411